Our results indicate that in NE-like cells, the Pax5 promoter is heavily methylated compared to adenocarcinoma cells (Fig. 7H and Table S2) and therefore raised the question of how a methylated Pax5 promoter becomes accessible for Pbx1 binding. Here, PAX5 is linked to adenocarcinoma.